GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | December 11, 2024 |
PDB ID | UniProt ID ▼ | Title | Descriptor |
---|---|---|---|
1P0M | P06276 | Crystal structure of human butyryl cholinesterase in complex with a choline molecule | |
1P0P | P06276 | Crystal structure of soman-aged human butyryl cholinesterase in complex with the substrate analog butyrylthiocholine | |
1P0Q | P06276 | Crystal structure of soman-aged human butyryl cholinesterase | |
1XLU | P06276 | X-Ray Structure Of Di-Isopropyl-Phosphoro-Fluoridate (Dfp) Inhibited Butyrylcholinesterase after Aging | |
1XLV | P06276 | Ethylphosphorylated Butyrylcholinesterase (Aged) Obtained By Reaction With Echothiophate | |
1XLW | P06276 | Diethylphosphorylated Butyrylcholinesterase (Nonaged) Obtained By Reaction With Echothiophate | |
2J4C | P06276 | Structure of human Butyrylcholinesterase in complex with 10mM HgCl2 | |
2PM8 | P06276 | Crystal structure of recombinant full length human butyrylcholinesterase | |
2WID | P06276 | NONAGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN ANALOGUE TA1 | |
2WIF | P06276 | AGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN ANALOGUE TA1 | |
2WIG | P06276 | NONAGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN ANALOGUE TA4 | |
2WIJ | P06276 | NONAGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN ANALOGUE TA5 | |
2WIK | P06276 | NONAGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN ANALOGUE TA6 | |
2WIL | P06276 | AGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN ANALOGUE TA5 | |
2WSL | P06276 | Aged Form of Human Butyrylcholinesterase Inhibited by Tabun Analogue TA4 | |
2XMB | P06276 | G117H mutant of human butyrylcholinesterase in complex with sulfate | |
2XMC | P06276 | G117H mutant of human butyrylcholinesterase in complex with fluoride anion | |
2XMD | P06276 | G117H mutant of human butyrylcholinesterase in complex with echothiophate | |
2XMG | P06276 | G117H mutant of human butyrylcholinesterase in complex with VX | |
2XQF | P06276 | X-ray Structure of human butyrylcholinesterase inhibited by racemic VX | |
2XQG | P06276 | X-ray Structure of human butyrylcholinesterase inhibited by racemic VR | |
2XQI | P06276 | X-ray Structure of human butyrylcholinesterase inhibited by racemic CVX | |
2XQJ | P06276 | X-ray Structure of human butyrylcholinesterase inhibited by pure enantiomer VX-(R) | |
2XQK | P06276 | X-ray Structure of human butyrylcholinesterase inhibited by pure enantiomer VX-(S) | |
2Y1K | P06276 | STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY CBDP (12H SOAK): PHOSPHOSERINE ADDUCT | |
3DJY | P06276 | Nonaged Form of Human Butyrylcholinesterase Inhibited by Tabun | |
3DKK | P06276 | Aged Form of Human Butyrylcholinesterase Inhibited by Tabun | |
4AQD | P06276 | Crystal structure of fully glycosylated human butyrylcholinesterase | |
4AXB | P06276 | Crystal structure of soman-aged human butyrylcholinesterase in complex with 2-PAM | |
4B0O | P06276 | Crystal structure of soman-aged human butyrylcholinesterase in complex with benzyl pyridinium-4-methyltrichloroacetimidate | |
4B0P | P06276 | Crystal structure of soman-aged human butyrylcholinesterase in complex with methyl 2-(pentafluorobenzyloxyimino)pyridinium | |
4BBZ | P06276 | Structure of human butyrylcholinesterase inhibited by CBDP (2-min soak): Cresyl-phosphoserine adduct | |
4BDS | P06276 | Human butyrylcholinesterase in complex with tacrine | |
4TPK | P06276 | Human butyrylcholinesterase in complex with N-((1-(2,3-dihydro-1H-inden-2-yl)piperidin-3-yl)methyl)-N-(2-methoxyethyl)-2-naphthamide | |
4XII | P06276 | X-ray structure of human butyrylcholinesterase in complex with N-((1-(2,3-dihydro-1H-inden-2-yl)piperidin-3-yl)methyl)-8-hydroxy-N-(2-methoxyethyl)-5-nitroquinoline-7-carboxamide | Butyrylcholinesterase (E.C.3.1.1.8) |
5DYT | P06276 | Crystal structure of human butyrylcholinesterase in complex with N-((1-benzylpiperidin-3-yl)methyl)-N-methylnaphthalene-2-sulfonamide | |
5DYW | P06276 | Crystal structure of human butyrylcholinesterase in complex with N-((1-benzylpiperidin-3-yl)methyl)-N-(2-methoxyethyl)naphthalene-2-sulfonamide | |
5DYY | P06276 | Crystal structure of human butyrylcholinesterase in complex with N-((1-benzylpiperidin-3-yl)methyl)naphthalene-2-sulfonamide | |
5K5E | P06276 | Discovery and Structure-Activity Relationships of a Highly Selective Butyrylcholinesterase Inhibitor by Structure-Based Virtual Screening | |
5LKR | P06276 | Human Butyrylcholinesterase complexed with N-Propargyliperidines | |
5NN0 | P06276 | Crystal structure of huBChE with N-((1-(2,3-dihydro-1H-inden-2-yl)piperidin-3-yl)methyl)-N-(2-(dimethylamino)ethyl)-2-naphthamide. | |
6F7Q | P06276 | Human Butyrylcholinesterase complexed with N-Propargyliperidines | |
6I0B | P06276 | Human butyrylcholinesterase in complex with the S enantiomer of a chlorotacrine-tryptophan multi-target inhibitor. | |
7QBQ | P06276 | Human butyrylcholinesterase in complex with (Z)-N-benzyl-1-(8-hydroxyquinolin-2-yl)methanimine oxide | |
7QBR | P06276 | Human butyrylcholinesterase in complex with (Z)-N-tert-butyl-1-(8-(3-(4-(prop-2-yn-1-yl)piperazin-1-yl)propoxy)quinolin-2-yl)methanimine oxide | |
7QHD | P06276 | Human Butyrylcholinesterase in complex with (S)-1-(4-((2-(1H-indol-3-yl)ethyl)carbamoyl)benzyl)-N-(3-((1,2,3,4-tetrahydroacridin-9-yl)amino)propyl)piperidine-3-carboxamide | |
7QHE | P06276 | Human Butyrylcholinesterase in complex with (S)-1-(4-((naphthalen-1-yl)carbamoyl)benzyl)-N-(3-((1,2,3,4-tetrahydroacridin-9-yl)amino)propyl)piperidine-3-carboxamide | |
7Q1M | P06276 | Crystal structure of human butyrylcholinesterase in complex with N-[(2S)-3-[(cyclohexylmethyl)amino]-2-hydroxypropyl]-2,2-diphenylacetamide | |
7Q1N | P06276 | Crystal structure of human butyrylcholinesterase in complex with N-[(2R)-3-[(cyclohexylmethyl)amino]-2-hydroxypropyl]-2,2-diphenylacetamide | |
7Q1O | P06276 | Crystal structure of human butyrylcholinesterase in complex with N-[(2S)-3-[(cyclohexylmethyl)amino]-2-hydroxypropyl]-3,3-diphenylpropanamide |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024